Skip to content
sellWeak cluster of 510b5-1 plan

Chrystal Jensen sold $105k of CERS

Chief Legal Officer at CERUS CORP. 66,292 shares at an average of $1.58, traded Mar 4, 2025, filed Mar 5, 2025.

Warning score
10
Value
$105k
66,292 shares
Holdings after
405,198
-14% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $105k at market
    +10
  • Share of holdings sold
    Sold 14% of holdings
    +5
  • Cluster
    5 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CERSOct 9, 2026 · close 2.30
Since filing Mar 5, 2025: +42.9%SPY +36.2% · excess +6.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000950170-25-034077, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 3, 2025MOption exercise
Common Stock10b5-1
+13,912--471,490Mar 5, 2025
Mar 4, 2025SOpen-market sale
Common Stock10b5-1
-6,292$1.55$9,743465,198Mar 5, 2025
Mar 4, 2025SOpen-market sale
Common Stock10b5-1
-60,000$1.59$95k405,198Mar 5, 2025
Mar 3, 2025MOption exercise
Restricted Stock Unitderivative10b5-1
-13,912--0Mar 5, 2025

Related signals

Other insiders at CERUS CORP and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
34Weak
CERSbuy
CERUS CORP
Dean A. Gregory
director
$31k
25,000 shares
+41%
18Weak
CERSsell 510b5-1
CERUS CORP
Richard J Benjamin
Chief Medical Officer
$71k
49,024 shares
-7%
26Weak
CERSsell 510b5-1
CERUS CORP
Kevin Dennis Green
Chief Financial Officer
$87k
59,887 shares
-6%
34Weak
CERSsell 510b5-1
CERUS CORP
William Mariner Greenman
President and CEO
$281k
193,913 shares
-4%
25Weak
CERSsell 510b5-1
CERUS CORP
Vivek K Jayaraman
Chief Operating Officer
$110k
75,989 shares
-5%
18Weak
CERSsell 510b5-1
CERUS CORP
Chrystal Jensen
Chief Legal Officer
$71k
49,024 shares
-6%
16Weak
CERSsell 510b5-1
CERUS CORP
Richard J Benjamin
Chief Medical Officer
$39k
26,139 shares
-3%
23Weak
CERSsell 510b5-1
CERUS CORP
Kevin Dennis Green
Chief Financial Officer
$47k
31,148 shares
-3%
29Weak
CERSsell 510b5-1
CERUS CORP
William Mariner Greenman
President and CEO
$91k
60,984 shares
-1%
22Weak
CERSsell 510b5-1
CERUS CORP
Vivek K Jayaraman
Chief Operating Officer
$51k
33,999 shares
-2%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Chrystal Jensen sold $105k of CERS | InsiderTell